SEARCH

SEARCH BY CITATION

REFERENCES

  • Appleton RE, Peters AC, Mumford JP, Shaw DE. (1999) Randomised, placebo-controlled study of vigabatrin as first-line treatment of infantile spasms. Epilepsia 40:16271633.
  • Arndt CF, Derambure P, Defoort-Williams S, Hache JC. (1999) Outer retinal dysfunction in patients treated with vigabatrin. Neurology 52:12011205.
  • Arndt CF, Salle M, Derambure PH, Defoort-Dhellemmes S, Hache JC. (2002) The effect on vision of associated treatments in patients taking vigabatrin: Carbamazepine versus valproate. Epilepsia 43:812817.
  • Ben-Menachem E, Persson LI, Schechter PJ, Haegele KD, Huebert N, Hardenberg J, Dahlgren L, Mumford JP. (1989) The effect of different vigabatrin treatment regimens on CSF biochemistry and seizure control in epileptic patients. British Journal of Clinical Pharmacology. 27(Suppl):7985.
  • Besch DA, Kurtenbach E, Apfelstedt-Sylla B, Sadowski B, Dennig D, Asenbauer C, Zrenner E, Schiefer U. (2002) Visual field constriction and electrophysiological changes associated with vigabatrin. Documenta Ophthalmologica 104:151170.
  • Chiron C, Dumas C, Jambaque I, Mumford J, Dulac O. (1997) Randomized trial comparing vigabatrin and hydrocortisone in infantile spasms due to tuberous sclerosis. Epilepsy Research 26:389395.
  • Daneshvar H, Racette L, Coupland SG, Kertes PJ, Guberman A, Zackon D. (1999) Symptomatic and asymptomatic visual loss in patients taking vigabatrin. Ophthalmology 106:17921798.
  • Eke T, Talbot JF, Lawden MC. (1997) Severe persistent visual field constriction associated with vigabatrin. British Medical Journal 314:180181.
  • Elterman RD, Shields WD, Mansfield KA, Nakagawa J. (2002) Randomized trial of vigabatrin in patients with infantile spasms. Neurology 57:14161421.
  • Fechtner RD, Khouri AS, Figueroa E, Ramirez M, Federico M, Dewey SL, Brodie JD. (2006) Short-term treatment of cocaine and/or methamphetamine abuse with vigabatrin. Archives of Ophthalmology 124:12571262.
  • Hancock E, Osborne J, Milner P. (2003) Treatment of infantile spasms. Cochrane Database Systematic Reviews; CD0011770.
  • Harding GFA, Wild JM, Robertson KA. Rietbrock S, Martinez C. (2000) Separating the retinal electrophysiological effects of vigabatrin – treatment versus field loss. Neurology 55:347352.
  • Harding GFA, Spencer EL, Wild JM, Conway M, Bohn RL (2002) Field-specific visual evoked potentials. Identifying field defects in vigabatrin-treated children. Neurology 58:12611266.
  • Hardus P, Verduin WM, Postma G, Stilma JS, Berendschot T, Van Veelen CWM. (2000) Concentric contraction of the visual field in patients with temporal lobe epilepsy and its association with the use of vigabatrin medication. Epilepsia 41:581587.
  • Hardus P, Verduin WM, Engelsman M, Edelbroek PM, Segers JP, Berendschot TT, Silma JS. (2001) Visual field loss associated with vigabatrin: Quantification and relation to dosage. Epilepsia 42:262267.
  • Harrington DO, Drake MV. (1990) The Visual Fields. Mosby , St Louis.
  • Kälviäinen R, Nousiainen I. (2001) Visual field defects with vigabatrin: epidemiology and therapeutic implications. CNS Drugs 15:217230.
  • Kälviäinen R, Aikiä M, Saukkonene AM, Mervaala E, Riekkinen PJ. (1995) Vigabatrin versus carbamazepine monotherapy in newly diagnosed patients with epilepsy. Archives of Neurology 52:989996.
  • Kälviäinen R, Nousiainen I, Mantyjarvi M, Nikoskelainen E, Partanen J, Partanen K, Riekkinen P. (1999) Vigabatrin, a gabaergic antiepileptic drug, causes concentric visual field defects. Neurology 53:922926.
  • Krauss GL, Johnson MA, Miller NR. (1998) Vigabatrin-associated retinal cone system dysfunction. Electroretinogram and ophthalmic findings. Neurology 50: 614618.
  • Lawden MC, Eke T, Degg C, Harding GFA, Wild JM. (1999) Visual field defects associated with vigabatrin therapy. Journal of Neurology, Neurosurgery and Psychiatry 67:716722.
  • Mackay MT, Weiss SK, Adams-Webber T, Ashwal S, Stephens D, Ballaban-Gill K, Baram TZ, Duchowny M, Hirtz D, Pellock JM, Shields WD, Shinnar S, Wyllie E, Sneed OC, American Academy of Neurology, Child Neurology Society. (2004) Practice parameter: medical treatment of infantile spasms: report of the American Academy of Neurology; Child Neurology Society. Neurology 62:16681681.
  • Manuchehri K, Goodman S, Siviter L, Nightingale S. (2000) A controlled study of vigabatrin and visual abnormalities. British Journal of Ophthalmology 84:499505.
  • McDonagh J, Stephen LJ, Dolan FM, Parks S, Dutton GN, Kelly K, Keating D, Sills GJ, Brodie MJ. (2003) Peripheral retinal dysfunction in patients taking vigabatrin. Neurology. 61:16901694.
  • Miller NR, Johnson MA, Paul, SR, Girkin CA, Perry JD, Endres M, Krauss GL. (1999) Visual dysfunction in patients receiving vigabatrin. Neurology 53:20822087.
  • Newman WD, Tocher, K Acheson JF. (2002) Vigabatrin associated visual field loss: a clinical audit to study prevalence, drug history and effects of drug withdrawal. Eye 16:567571.
  • Nicolson A, Leach JP, Chadwick DW, Smith DF. (2002) The legacy of vigabatrin in a regional epilepsy clinic. Journal of Neurology, Neurosurgery and Psychiatry 73:327329.
  • Nousiainen I, Mantyjarvi M, Kälviäinen R. (2001) No reversion in vigabatrin-associated visual field defects. Ophthalmology 57:19161917.
  • Riekkinen PJ, Ylinen A, Halonen T, Sivenius J, Pitkanen A. (1989) Cerebrospinal fluid, GABA and seizure control with vigabatrin. British Journal of Clinical Pharmacology 27(Suppl):8794.
  • Schechter PJ. (1989) Clinical pharmacology of vigabatrin. British Journal of Clinical Pharmacology 27(Suppl):1922.
  • Stefan HJ, Bernati K, Knorr HLJ. (2000) Visual field constriction and anti-epileptic drug treatment. Neurology, Psychiatry and Brain Research 7:185190.
  • Vanhatalo S, Nousiainen I, Eriksson K, Rantala H, Vainionpaa L, Mustonen K, Aarimaa T, Alen R, Aine MR, Byring R, Hirvasiemi A, Nuutila A, Walden T, Ritanen-Mohammed UM, Karttunen-Lewandowski P, Pohjola LM, Kaksonen S, Jurvelin P, Granstrom ML. (2002) Visual field constriction in 91 Finnish children treated with vigabatrin. Epilepsia 43:748756.
  • Westall CA, Logan WJ, Smith K, Buncic JR, Panton CM, Abdolell M. (2002) The Hospital for Sick Children, Toronto, Longitudinal ERG study of children on vigabatrin. Documenta Ophthalmologica. 104:133149.
  • Wild JM, Flanagan JG, Barnes DA, Gilmartin BA, Good PA, Crews SJ. (1984) The qualitative comparative analysis of the visual field using computer-assisted, semi-automated and manual instrumentation. II. Statistical analysis. Documenta Ophthalmologica 58:319324.
  • Wild JM, Martinez C, Reinshagen G, Harding GFA. (1999) Characteristics of a unique visual field defect attributed to vigabatrin. Epilepsia 40:17841794.
  • Wild JM, Robson CR, Jones A, Cunliffe IA, Smith PEM. (2006) Detecting vigabatrin toxicity by imaging of the retinal nerve fibre layer. Investigative Ophthalmology and Visual Science 47:917924